We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery... Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Show more
SALT LAKE CITY, May 13, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the...
On track to read out multiple Phase 2 clinical trials in the coming quarters, beginning in Q3 2024Performance benchmarking completed on BioHive-2, Recursion's next generation supercomputer, which...
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will...
SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
SALT LAKE CITY, April 30, 2024 (GLOBE NEWSWIRE) -- Altitude Lab and the Small Business Administration (SBA) are pleased to announce Horizon, a commercialization program to connect startups to...
SALT LAKE CITY, April 16, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery and...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.48 | 17.2897196262 | 8.56 | 10.665 | 8.22 | 7620435 | 9.34361423 | CS |
4 | 2.4 | 31.4136125654 | 7.64 | 10.665 | 7.135 | 5044180 | 8.55161894 | CS |
12 | -2.16 | -17.7049180328 | 12.2 | 15.74 | 7.135 | 6153933 | 10.72574832 | CS |
26 | 3.54 | 54.4615384615 | 6.5 | 15.74 | 6.31 | 6011741 | 10.33698614 | CS |
52 | 4.73 | 89.077212806 | 5.31 | 16.745 | 4.92 | 5418584 | 10.23980934 | CS |
156 | -11.45 | -53.2805956259 | 21.49 | 42.81 | 4.54 | 2510908 | 10.81163208 | CS |
260 | -19.96 | -66.5333333333 | 30 | 42.81 | 4.54 | 2459925 | 10.96630342 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions